|
[1] ZHANG YN, XU Y, JIANG C, et al. Diagnosis and treatment of inherited metabolic liver disease[J]. J Clin Hepatol, 2019, 35 (4) :921-924. (in Chinese) 张亚南, 许影, 蒋畅, 等.遗传代谢性肝病的诊治[J].临床肝胆病杂志, 2019, 35 (4) :921-924.
|
|
[2] KIM JS, KIM KM, OH SH, et al. Liver transplantation for metabolic liver disease:Experience at a living donor dominant liver transplantation center[J]. Pediatr Gastroenterol Hepatol Nutr, 2015, 18 (1) :48-54.
|
|
[3] ONNERHAG K, DREJA K, NILSSON PM, et al. Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities[J]. Clin Res Hepatol Gastroenterol, 2019.[Epub ahead of print]
|
|
[4] AHN AL, CHOI JK, KIM MN, et al. Non-alcoholic fatty liver disease and chronic kidney disease in Koreans aged 50 years or older[J]. Korean J Fam Med, 2013, 34 (3) :199-205.
|
|
[5] TARGHER G, CHONCHOL M, ZOPPINI G, et al. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease:Is there a link?[J]. J Hepatol, 2011, 54 (5) :1020-1029.
|
|
[6] ALAM S, SOOD V. Metabolic liver disease:When to suspect and how to diagnose?[J]. Indian J Pediatr, 2016, 83 (11) :1321-1333.
|
|
[7] ROY A, SAMANTA T, PURKAIT R, et al. Etiology, clinical spectrum and outcome of metabolic liver diseases in children[J]. J Coll Physicians Surg Pak, 2013, 23 (3) :194-198.
|
|
[8] YAMAGUCHI K, WAKIMIZU R, KUBOTA M. Difficulties in daily life and associated factors, and qol of children with inherited metabolic disease and their parents in Japan:A literature review[J]. JIMD Rep, 2017, 33:1-10.
|
|
[9] BRYSON TE, ANGLIN CM, BRIDGES PH, et al. Nucleasemediated gene therapies for inherited metabolic diseases of the liver[J]. Yale J Biol Med, 2017, 90 (4) :553-566.
|
|
[10] KOSHY A, RAMASWAMY K, CORREA M, et al. Glycogen storage disease:Report of 17 cases from southern India[J].Indian J Gastroenterol, 2006, 25 (4) :182-184.
|
|
[11] ZHANG ZH, LIN WX, DENG M, et al. Clinical, molecular and functional investigation on an infant with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) [J]. PLo S One, 2014, 9:e89267.
|
|
[12] PANT M, OSHIMA K. Cholesteryl ester storage disease:An underdiagnosed cause of cirrhosis in adults[J]. Ann Diagn Pathol, 2017, 31:66-70.
|
|
[13] NICOLAOU M, ANDRESS EJ, ZOLNERCIKS JK, et al. Canalicular ABC transporters and liver disease[J]. J Pathol, 2012, 226 (2) :300-315.
|
|
[14] JOSHI D, GUPTA N, SAMYN M, et al. The management of childhood liver diseases in adulthood[J]. J Hepatol, 2017, 66 (3) :631-644.
|
|
[15] YU H, XIE XB. Current perspectives on the etiology, diagnosis, and treatment of pediatric acute liver failure[J]. J ClinHepatol, 2012, 28 (12) :899-901. (in Chinese) 俞蕙, 谢新宝.儿童急性肝衰竭的病因及诊治[J].临床肝胆病杂志, 2012, 28 (12) :899-901.
|
|
[16] DEVICTOR D, TISSIERES P, DURAND P, et al. Acute liver failure in neonates, infants and children[J]. Expert Rev Gastroenterol Hepatol, 2011, 5 (6) :717-729.
|
|
[17] SQUIRES RJ, SHNEIDER BL, BUCUVALAS J, et al. Acute liver failure in children:The first 348 patients in the pediatric acute liver failure study group[J]. J Pediatr, 2006, 148 (5) :652-658.
|
|
[18] DHAWAN A. Etiology and prognosis of acute liver failure in children[J]. Liver Transpl, 2008, 14 (Suppl 2) :s80-s84.
|
|
[19] SATHE KP, NAGRAL A. Metabolic liver disease in developing world with special reference to Indian children-A review[J].Apollo Med, 2015, 12 (1) :22-31.
|
|
[20] ARNON R, KERKAR N, DAVIS MK, et al. Liver transplantation in children with metabolic diseases:The studies of pediatric liver transplantation experience[J]. Pediatr Transplant, 2010, 14 (6) :796-805.
|
|
[21] STEVENSON T, MILLAN MT, WAYMAN K, et al. Long-term outcome following pediatric liver transplantation for metabolic disorders[J]. Pediatric Transplant, 2010, 14 (2) :268-275.
|
|
[22] LI D, LIN Y, HUANG Y, et al. Early prenatal diagnosis of lysosomal storage disorders by enzymatic and molecular analysis[J]. Prenat Diagn, 2018, 38 (3) :779-787.
|
|
[23] SCHADY DA, FINEGOLD MJ. Contemporary evaluation of the pediatric liver biopsy[J]. Gastroenterol Clin North Am, 2017, 46 (2) :233-252.
|
|
[24] YF Y. Atlas of liver pathology[M]. Changsha:Central-South University Publishing Group, 2018:52-75. (in Chinese) 杨永峰.肝脏病理学图解[M].长沙:中南大学出版社, 2018:52-75.
|
|
[25] YANG YF, XIONG QF. Histopathological features and diagnostic consideration of genetic metabolic liver diseases[J].Chin J Hepatol, 2018, 26 (12) :885-888. (in Chinese) 杨永峰, 熊清芳.遗传代谢性肝病的组织病理学特征和诊断思路[J].中华肝脏病杂志, 2018, 26 (12) :885-888.
|
|
[26] WASKOWICZ LR, ZHOU J, LANDAU DJ, et al. Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia[J]. Hum Mol Genet, 2019, 28 (1) :143-154.
|
|
[27] ADAMS DR, ENG CM. Next-generation sequencing to diagnose suspected genetic disorders[J]. N Engl J Med, 2019, 380 (2) :201.
|
|
[28] NG SB, BUCKINGHAM KJ, LEE C, et al. Exome sequencing identifies the cause of a mendeliandisorder[J]. Nat Genet, 2010, 42 (1) :30-35.
|
|
[29] TANG W, MAKUUCHI M. Intractable and rare diseases research[J]. Biosci Trends, 2012, 6 (2) :48-51.
|
DownLoad: